Julphar Bangladesh Launched latest Methylxanthine- Doxair (Doxophylline 400 mg Tablet)
Julphar Bangladesh has launched another breakthrough Molecule Doxair (Doxophylline 400 mg Tablet) for Better management of Asthma & COPD
- Provides both Bronchodilatory and Anti-inflammatory effect
- Shows outstanding efficacy in Asthma & COPD
- Ensures Cardiac safety
- Ensures normal sleep
- Ensures Renal & GI safety
- DMF grade best quality API
1 tablet once daily in the evening. Dose may be increased up to 1 tablet thrice daily depend on response.
Child > 6 years: 6 mg/kg twice daily. The dose may be increased up to 18 mg/kg daily on the basis of medical response.